The Validation Triad: Sterilisation, Shelf Life and Reprocessing of Reusable Devices

This article is issue 29 of Volume 3, Registration Dossiers and Technical Requirements, of the 50-article series on medical device registration in Switzerland. Together with the other nine issues in this volume it forms a complete deliverable on this topic; the publication timestamp, issue number, title and unique URL are shown in the table below.

1. Key takeaways

Sterilisation validation, shelf-life validation and validation of reprocessing for reusable devices are not three independent reports; they form one chain. Section 10 of EU MDR Annex I (covering chemical, physical and biological properties) and Section 11 (covering requirements related to infection and microbial contamination) become Swiss law through MedDO Art. 6(2). The three constrain each other: the upper limit of reprocessing cycles comes from reprocessing validation, the shelf life comes from stability validation, and together the two determine the integrity claims for sterilisation packaging and the sterile barrier system. If any one number is inconsistent, the whole chain breaks — for example, an instructions for use claiming 20 reprocessing cycles when the validation only ran to 10.

2. Legal basis

3. Expert insights

1. Shelf-life claims must align strictly with validation data — no number beyond conservatism. The routine approach to shelf-life validation is to run accelerated ageing and real-time ageing in parallel: accelerated ageing supports early market entry, real-time ageing provides final confirmation. The high-risk practice is to write the accelerated ageing result directly into the instructions for use as the shelf life while the real-time data are still incomplete. Once real-time data contradict the claim, the shelf-life statement on products already on the market becomes misleading information about safety and performance under Art. 16(7). The safe approach is to label the product first with the more conservative accelerated-ageing conclusion and extend it once the real-time data arrive, even though this sacrifices an early shelf-life selling point — a genuine trade-off between commerce and compliance.

2. Reprocessing validation for reusable devices faces an extra third-party threshold in Switzerland. MedDO Art. 23 combined with EU MDR Art. 52 governs conformity assessment, and reusable surgical instruments require a certificate issued by a notified body under the MDR. For such devices, reprocessing validation is therefore not merely a report inside the technical documentation; it becomes an object of substantive notified body review. The review focus is usually whether the cleaning, disinfection and sterilisation steps cover the worst case (the hardest-to-clean device configuration, the highest soiling load, the least manual pre-cleaning), and whether the upper limit of reprocessing cycles is supported by data. Preparing these as two documents — a worst-case rationale and a validation matrix — passes review more easily than a single generic validation report (practical estimate).

3. The shared blind spot of the triad is the instructions for use. The conclusions of all three validations — sterilisation, stability and reprocessing — finally land in the instructions for use: sterilisation method and parameters, shelf life and storage conditions, reprocessing steps and cycle limits. Switzerland adds a further layer: Art. 16(2) requires the instructions for use to be written in German, French and Italian. If any parameter differs between the language versions — for example, the German version stating 134 ℃ and the French version stating 121 ℃ — this breaches the language requirement of Art. 16(2) and may also cross the prohibition on misleading information in Art. 16(7). A consistency check of technical parameters across the language versions should be a mandatory step before the instructions are finalised, owned by a named reviewer.

4. Practical recommendations

1. Build a consistency check sheet for the triad: the three numbers — reprocessing cycle limit, shelf life and sterilisation parameters — must match exactly in the validation reports, the technical documentation and the instructions for use.
2. Label the shelf life first with the conservative accelerated-ageing conclusion, and extend it through the change process once real-time ageing data arrive.
3. For reusable surgical instruments, prepare notified body review materials under Art. 23 combined with EU MDR Art. 52, focusing on worst-case rationale and the validation matrix.
4. Add a multilingual technical parameter consistency check before the instructions for use are finalised, covering German, French and Italian.
5. Any change to the triad — sterilisation method, packaging material, reprocessing steps — triggers the change classification assessment described in issue 30.

5. Verification checklist

• □ The sterilisation validation report covers the sterilisation method, parameters and sterile barrier system integrity
• □ Accelerated ageing data exist for the shelf life, and the real-time ageing plan and change triggers are defined
• □ Reusable devices have reprocessing validation for cleaning, disinfection and sterilisation, with the basis for the cycle limit
• □ The three key numbers of the triad match in the validation reports, the technical documentation and the instructions for use
• □ Technical parameters in the German, French and Italian versions of the instructions have been checked for consistency
• □ The notified body certificate requirement for reusable surgical instruments has been confirmed (Art. 23 combined with EU MDR Art. 52)

Legal information verified as of 29 October 2026.

GRZAN provides registration documentation and conformity file support for the Swiss market: sterilisation and reprocessing validation reviews, shelf-life justification packages, worst-case rationales and validation matrices for notified body review, and multilingual parameter consistency checks. Our technical writing team keeps your validation chain aligned end to end. For assistance, contact GRZAN at info@grzanglobal.com.